RNS Number : 2054C
Tavistock Investments PLC
21 February 2022
Tavistock Investments Plc
("Tavistock" or the "Company")
Transaction in own shares and total voting rights
21 February 2022
Tavistock announces that, on 21 February 2022, in accordance with the authority granted by shareholders at the Company's General Meeting held on 23 July 2021 and as signalled in the Company's 2021 final results announced on 7 September 2021, the Company has purchased 21,219,847 of its own ordinary shares of 1 penny each ("Ordinary Shares"), representing 3.67 % of the shares in issue, at a price of 5.85 pence per share (the "Buyback Shares").
The Buyback Shares will now be cancelled.
Once the Buyback Shares have been cancelled, the Company will have 557,677,576 Ordinary Shares in issue. Therefore, the total number of voting rights in the Company will be 557,677,576 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure Guidance and Transparency Rules.
Assuming no further issue of Ordinary Shares, the earnings per share is expected to increase by 3.3% per Ordinary Share as a result of this transaction.
|
For further information
|
Tavistock Investments Plc
Oliver Cooke
Brian Raven
|
Tel: 01753 867000
|
|
Allenby Capital Limited (Nominated adviser and broker)
Corporate Finance: Nick Naylor, Nick Athanas, Liz Kirchner
Sales and Corporate Broking: Tony Quirke
|
Tel: 020 3328 5656
|
|
Powerscourt
Gilly Lock
Chloe Retief
|
Tel: 07711 380 007
020 7250 1446
|
|
|
|
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
[email protected] or visit
www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy.
END
POSEAPAEAAKAEFA